In addition, strong expression of Ki-67, partial expression of EGFR and VEGF, and weak expression of MGMT and HIF-1α was oberserved on immunohistochemical staining, These supplementary characteristics will make GSC glioma model a better test platform for glioma. This evidence concerns the gene VEGFA and central nervous system cancer.